4//SEC Filing
Sofinnova HealthQuest Partners, L.P. 4
Accession 0001104659-20-008862
CIK 0001447362other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 6:52 PM ET
Size
8.7 KB
Accession
0001104659-20-008862
Insider Transaction Report
Form 4
Kong Garheng
10% Owner
Transactions
- Sale
Common Stock
2020-01-28$30.02/sh−25,000$750,493→ 1,808,577 total
Transactions
- Sale
Common Stock
2020-01-28$30.02/sh−25,000$750,493→ 1,808,577 total
Sofinnova HealthQuest Partners, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-01-28$30.02/sh−25,000$750,493→ 1,808,577 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Healthquest Partners, L.P. on December 17, 2019.
- [F2]The shares are directly held by Sofinnova HealthQuest Partners, L.P. ("HealthQuest"). HealthQuest Venture Management, L.L.C. ("HQVM"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein.
Documents
Issuer
CASTLE BIOSCIENCES INC
CIK 0001447362
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001579382
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 6:52 PM ET
- Size
- 8.7 KB